Protective Effect of PACAP on Ischemia/Reperfusion-Induced Kidney Injury of Male and Female Rats: Gender Differences

[1]  A. Tamas,et al.  Altered Notch Signaling in Developing Molar Teeth of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Deficient Mice , 2018, Journal of Molecular Neuroscience.

[2]  V. May,et al.  PACAP-Induced PAC1 Receptor Internalization and Recruitment of Endosomal Signaling Regulate Cardiac Neuron Excitability , 2018, Journal of Molecular Neuroscience.

[3]  M. Nelson,et al.  PACAP38-Mediated Bladder Afferent Nerve Activity Hyperexcitability and Ca2+ Activity in Urothelial Cells from Mice , 2018, Journal of Molecular Neuroscience.

[4]  A. Tamas,et al.  Intestinal Microbiota Changes in Mice Lacking Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) – Bifidobacteria Make the Difference , 2017, European journal of microbiology & immunology.

[5]  A. Tamas,et al.  Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides , 2017, Progress in Neurobiology.

[6]  C. Extavour,et al.  Bone Morphogenetic Protein (BMP) signaling in animal reproductive system development and function. , 2017, Developmental biology.

[7]  A. James,et al.  BMP-2-induced bone formation and neural inflammation. , 2017, Journal of orthopaedics.

[8]  A. Tamas,et al.  Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice , 2017, Journal of Vascular Research.

[9]  E. Pessoa,et al.  Calcium oxalate crystals and oxalate induce an epithelial-to-mesenchymal transition in the proximal tubular epithelial cells: Contribution to oxalate kidney injury , 2017, Scientific Reports.

[10]  A. Tamas,et al.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP , 2017, Journal of Molecular Neuroscience.

[11]  T. Yukimura,et al.  Sex differences in ischaemia/reperfusion‐induced acute kidney injury depends on the degradation of noradrenaline by monoamine oxidase , 2017, Clinical and experimental pharmacology & physiology.

[12]  W. Banks,et al.  Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents , 2017, International journal of molecular sciences.

[13]  J. Hannibal,et al.  Pituitary adenylate cyclase‐activating polypeptide promotes eccrine gland sweat secretion , 2017, The British journal of dermatology.

[14]  S. Kyo,et al.  Interactions between Two Different G Protein-Coupled Receptors in Reproductive Hormone-Producing Cells: The Role of PACAP and Its Receptor PAC1R , 2016, International journal of molecular sciences.

[15]  Z. Nagy,et al.  Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma , 2016, Journal of Molecular Neuroscience.

[16]  R. Goldschmeding,et al.  Age-dependent shifts in renal response to injury relate to altered BMP6/CTGF expression and signaling. , 2016, American journal of physiology. Renal physiology.

[17]  Ingela Lanekoff,et al.  PACAP suppresses dry eye signs by stimulating tear secretion , 2016, Nature Communications.

[18]  M. Nematbakhsh,et al.  The Protective Effect of γ-aminobutyric Acid on Kidney Injury Induced by Renal Ischemia-reperfusion in Ovariectomized Estradiol-treated Rats , 2016, International Journal of Preventive Medicine.

[19]  A. Tamas,et al.  Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice. , 2015, Transplantation proceedings.

[20]  M. Nematbakhsh,et al.  Effect of Γ-aminobutyric acid on kidney injury induced by renal ischemia-reperfusion in male and female rats: Gender-related difference , 2015, Advanced biomedical research.

[21]  A. Tamas,et al.  PACAP and VIP signaling in chondrogenesis and osteogenesis , 2015, Peptides.

[22]  H. Korashy,et al.  Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis. , 2015, Chemico-biological interactions.

[23]  Rong-jie Yu,et al.  Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity through Wnt/β-Catenin Pathways that Are Associated with Dimer Endocytosis , 2014, PloS one.

[24]  S. K. Park,et al.  Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice , 2014, Molecular medicine reports.

[25]  Tajpreet Kaur,et al.  Involvement of progesterone receptors in ascorbic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury. , 2014, The Journal of surgical research.

[26]  A. Tamas,et al.  Molecular Mechanisms Underlying the Nephroprotective Effects of PACAP in Diabetes , 2014, Journal of Molecular Neuroscience.

[27]  J. Neugarten,et al.  Gender and the prevalence and progression of renal disease. , 2013, Advances in chronic kidney disease.

[28]  T. He,et al.  Wnt signaling in bone formation and its therapeutic potential for bone diseases , 2013, Therapeutic advances in musculoskeletal disease.

[29]  A. Tamas,et al.  Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion , 2012, Neuroscience Letters.

[30]  A. Lakatos,et al.  PACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice , 2012, Journal of Molecular Neuroscience.

[31]  A. Tamas,et al.  Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney , 2012, Neuropeptides.

[32]  C. Deng,et al.  TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation , 2012, International journal of biological sciences.

[33]  D. Reglodi,et al.  Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: In vivo study with gene-deleted mice , 2011, Peptides.

[34]  A. Tamas,et al.  Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. , 2011, Current pharmaceutical design.

[35]  S. Shioda,et al.  Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[36]  D. Reglodi,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide Deficiency Enhances Oxazolone-Induced Allergic Contact Dermatitis in Mice , 2010, Journal of Molecular Neuroscience.

[37]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.

[38]  M. Menger,et al.  Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds? , 2007, Transplantation proceedings.

[39]  W. Spielman,et al.  Sex differences in inflammatory cytokine production in hepatic ischemia-reperfusion , 2006, Journal of Inflammation.

[40]  A. Tamas,et al.  Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats , 2006, Neuropeptides.

[41]  F. Gallyas,et al.  Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis , 2006, Peptides.

[42]  K. Meldrum,et al.  Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. , 2005, Cardiovascular research.

[43]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[44]  T. Kita,et al.  Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation* , 2004, Journal of Biological Chemistry.

[45]  L. Toledo-Pereyra,et al.  Ischemia/reperfusion injury. , 2002, The Journal of surgical research.

[46]  S. Lim,et al.  Upregulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha in rat kidney with ischemia-reperfusion injury. , 2001, Journal of the American Society of Nephrology : JASN.

[47]  V. Batuman,et al.  Renoprotective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide 38 (PACAP38) , 2016 .

[48]  S. Shioda,et al.  PACAP and Neural Development , 2016 .

[49]  T. Watabe,et al.  Bone Morphogenetic Proteins. , 2016, Cold Spring Harbor perspectives in biology.

[50]  A. Tamas,et al.  Protective Intestinal Effects of Pituitary Adenylate Cyclase Activating Polypeptide , 2016 .

[51]  J. Pisegna,et al.  PACAP Regulation of Gastrointestinal Function and Obesity , 2016 .

[52]  Self-Concept Variables.  Sex Differences in , 2016 .

[53]  A. Tamas,et al.  Effects of PACAP on Oxidative Stress-Induced Cell Death in Rat Kidney and Human Hepatocyte Cells , 2010, Journal of Molecular Neuroscience.

[54]  森 敬善.  Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice , 2010 .